ATE451367T1 - Verfahren zur herstellung von ziprasidon - Google Patents

Verfahren zur herstellung von ziprasidon

Info

Publication number
ATE451367T1
ATE451367T1 AT05708625T AT05708625T ATE451367T1 AT E451367 T1 ATE451367 T1 AT E451367T1 AT 05708625 T AT05708625 T AT 05708625T AT 05708625 T AT05708625 T AT 05708625T AT E451367 T1 ATE451367 T1 AT E451367T1
Authority
AT
Austria
Prior art keywords
ziprasidone
relates
preparation
substantially pure
producing
Prior art date
Application number
AT05708625T
Other languages
English (en)
Inventor
Yatendra Kumar
Mohan Prasad
Mahivir Khanna
Seema Ahuja
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Application granted granted Critical
Publication of ATE451367T1 publication Critical patent/ATE451367T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
AT05708625T 2004-02-27 2005-02-28 Verfahren zur herstellung von ziprasidon ATE451367T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN307DE2004 2004-02-27
IN1395DE2004 2004-07-28
PCT/IB2005/000512 WO2005085240A2 (en) 2004-02-27 2005-02-28 Process for the preparation of ziprasidone

Publications (1)

Publication Number Publication Date
ATE451367T1 true ATE451367T1 (de) 2009-12-15

Family

ID=34921521

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05708625T ATE451367T1 (de) 2004-02-27 2005-02-28 Verfahren zur herstellung von ziprasidon

Country Status (7)

Country Link
US (2) US20080312254A1 (de)
EP (1) EP1720867B1 (de)
AT (1) ATE451367T1 (de)
DE (1) DE602005018171D1 (de)
ES (1) ES2334800T3 (de)
PT (1) PT1720867E (de)
WO (1) WO2005085240A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2250000B1 (es) * 2004-09-29 2007-06-01 Medichem, S.A. Procedimiento para la preparacion de ziprasidona.
HU230479B1 (hu) * 2006-05-02 2016-07-28 Richter Gedeon Nyrt. Eljárás 5-{2-[4-(1,2-benzizotiazol-3-il)-1-piperazinil]-etil}-6-klór-1,3-dihidro-2H-indol-2-on (Ziprasidon) előállítására
WO2010010566A1 (en) * 2008-07-25 2010-01-28 Lupin Limited Improved process for the manufacture of ziprasidone

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US5206366A (en) * 1992-08-26 1993-04-27 Pfizer Inc. Process for preparing aryl piperazinyl-heterocyclic compounds
US5338846A (en) * 1992-08-26 1994-08-16 Pfizer Inc. Process for preparing aryl piperazinyl-heterocyclic compounds with a piperazine salt
US5312925A (en) * 1992-09-01 1994-05-17 Pfizer Inc. Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride
IL126590A (en) * 1996-05-07 2001-11-25 Pfizer Trihydrate salt of -5 (-2 (-4 (1 (2, 2-benzothiazole - 3yl) -1-piperazinyl) ethyl) - 6-chloro-1, 3-dihydro-2 (1H) - indole - 2On (= Ziprasidone) and pharmaceutical preparations containing it
US6150366A (en) * 1998-06-15 2000-11-21 Pfizer Inc. Ziprasidone formulations
UY27668A1 (es) * 2002-02-20 2003-10-31 Pfizer Prod Inc Composición de ziprasidona y controles sintéticos
WO2004050655A1 (en) * 2002-12-04 2004-06-17 Dr. Reddy's Laboratories Limited Polymorphic forms of ziprasidone and its hydrochloride
AU2003245027A1 (en) * 2003-04-11 2004-11-01 Hetero Drugs Limited Novel crystalline forms of ziprasidone hydrochloride
CA2528100A1 (en) * 2003-06-03 2005-04-21 Teva Pharmaceutical Industries Ltd Polymorphic forms of ziprasidone hcl and processes for their preparation
US20050049295A1 (en) * 2003-06-12 2005-03-03 Dr. Reddy's Laboratories Limited Process for the preparation of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1piperazinyl) ethyl)-6-chloro-1, 3-dihydro-2h-indol-2-one hydrochloride (ziprasidone hydrochloride) and its intermediate
US7667037B2 (en) * 2003-10-24 2010-02-23 Teva Pharmaceutical Industries Ltd. Processes for preparation of ziprasidone

Also Published As

Publication number Publication date
DE602005018171D1 (de) 2010-01-21
PT1720867E (pt) 2010-01-28
US8178674B2 (en) 2012-05-15
WO2005085240A2 (en) 2005-09-15
EP1720867A2 (de) 2006-11-15
WO2005085240A3 (en) 2005-12-01
US20110207933A1 (en) 2011-08-25
US20080312254A1 (en) 2008-12-18
ES2334800T3 (es) 2010-03-16
EP1720867B1 (de) 2009-12-09

Similar Documents

Publication Publication Date Title
DE602005017503D1 (de) Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
DE602005017027D1 (de) Verfahren zur enzymatischen herstellung von (s)-3-cyano-5-methylhexansäure
DE602005023877D1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
DE602005020360D1 (de) Verfahren zur herstellung von titan
EA201100094A1 (ru) Тиадиазолилоксифениламидины и их применение в качестве фунгицидов
ATE476414T1 (de) Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen
ATE529409T1 (de) Verfahren zur herstellung von kristallinen aripiprazolformen
DE602005018601D1 (de) Verfahren zur herstellung von 2-aminothiazol-5-aro
CY1112253T1 (el) Ενωσεις διαμινοτριαζολιου χρησιμες ως αναστολεις κινασης πρωτεϊνης
MXPA05012061A (es) Preparacion y uso de derivados alquilarilo para el tratamiento de la obesidad.
DE602004031895D1 (de) Verfahren zur Herstellung von Dichlorpropanol
DE60302682D1 (de) Verfahren zur Herstellung von Nanopartikeln
ATE538651T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
ATE504580T1 (de) Malonsäureamidderivate als inhibitoren von g- sekretase zur behandlung von alzheimer-krankheit
DE502005000428D1 (de) Verfahren zur Herstellung von 1,2-Diaminocyclohexan-Platin(II)-Komplexen
ATE496914T1 (de) Verfahren zur synthese von triazolen
DE602005024566D1 (de) Verfahren zur herstellung von 2-amino-5-iodobenzoesäure
DE502006004187D1 (de) Verfahren zur herstellung von diorganopolysiloxanen
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
ATE447567T1 (de) Verfahren zur herstellung von tryptase- inhibitoren
DE602005014280D1 (de) Verfahren zur herstellung von ä1,4,5ü-oxadiazepinderivaten
DE602004005137D1 (de) Verfahren zur Herstellung von Nanopartikeln
DE502006004524D1 (de) Verfahren zur herstellung von 3,7-diaza-bicycloä3.3.1ünonan-verbindungen
DE602004021358D1 (de) Benzosulfonamide derivate, deren verfahren zum herstellung, und deren verwendung zur behandlung von schmerzen
DE602004006118D1 (de) 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties